StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.53−0.01 (-1.40%)

Close on Nov 16, 2026Market cap $14.48MP/E –Yield –

Citius Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Citius Pharmaceuticals's total assets was $142.26M at Jun 30, 2026. For fiscal 2025 it was $130.94M, up 12.2% from the year before. Over ten years it grew 296.9% a year on average. The highest annual figure on record is $142.43M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Sep 30, 2025$130.94M+12.2%
FY2024Sep 30, 2024$116.65M+12.6%
FY2023Sep 30, 2023$103.61M-9.1%
FY2022Sep 30, 2022$114.00M-20.0%
FY2021Sep 30, 2021$142.43M+225.4%
FY2020Sep 30, 2020$43.77M+19.1%
FY2019Sep 30, 2019$36.75M+18.3%
FY2018Sep 30, 2018$31.05M+27.2%
FY2017Sep 30, 2017$24.42M+11.2%
FY2016Sep 30, 2016$21.95M+16259411.9%
FY2012Sep 30, 2012$135-36.3%
FY2011Sep 30, 2011$212–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$142.26M+11.4%
Q2 FY2026CQ1 2026Mar 31, 2026$132.54M+9.1%
Q1 FY2026CQ4 2025Dec 31, 2025$140.39M+16.3%
Q4 FY2025CQ3 2025Sep 30, 2025$130.94M+12.2%
Q3 FY2025CQ2 2025Jun 30, 2025$127.68M+31.5%
Q2 FY2025CQ1 2025Mar 31, 2025$121.48M+33.9%
Q1 FY2025CQ4 2024Dec 31, 2024$120.70M+23.9%
Q4 FY2024CQ3 2024Sep 30, 2024$116.65M+12.6%
Q3 FY2024CQ2 2024Jun 30, 2024$97.09M-12.1%
Q2 FY2024CQ1 2024Mar 31, 2024$90.71M-18.8%
Q1 FY2024CQ4 2023Dec 31, 2023$97.40M-14.6%
Q4 FY2023CQ3 2023Sep 30, 2023$103.61M-13.9%
Q3 FY2023CQ2 2023Jun 30, 2023$110.40M-13.6%
Q1 FY2023CQ4 2022Dec 31, 2022$111.71M-18.8%
Q4 FY2022CQ3 2022Sep 30, 2022$114.00M-20.0%
Q3 FY2022CQ2 2022Jun 30, 2022$120.32M-17.9%
Q2 FY2022CQ1 2022Mar 31, 2022$127.79M-5.1%
Q1 FY2022CQ4 2021Dec 31, 2021$137.52M+289.4%
Q4 FY2021CQ3 2021Sep 30, 2021$142.43M+225.4%
Q3 FY2021CQ2 2021Jun 30, 2021$146.59M+281.8%
Q2 FY2021CQ1 2021Mar 31, 2021$134.67M+408.3%
Q1 FY2021CQ4 2020Dec 31, 2020$35.31M+41.3%
Q4 FY2020CQ3 2020Sep 30, 2020$43.77M+19.1%
Q3 FY2020CQ2 2020Jun 30, 2020$38.40M+50.3%
Q2 FY2020CQ1 2020Mar 31, 2020$26.49M+9.3%
Q1 FY2020CQ4 2019Dec 31, 2019$24.98M-11.0%
Q4 FY2019CQ3 2019Sep 30, 2019$36.75M+18.3%
Q3 FY2019CQ2 2019Jun 30, 2019$25.54M+7.2%
Q2 FY2019CQ1 2019Mar 31, 2019$24.24M-7.0%
Q1 FY2019CQ4 2018Dec 31, 2018$28.08M-1.4%
Q4 FY2018CQ3 2018Sep 30, 2018$31.05M+27.2%
Q3 FY2018CQ2 2018Jun 30, 2018$23.83M+10.5%
Q2 FY2018CQ1 2018Mar 31, 2018$26.06M+22.2%
Q1 FY2018CQ4 2017Dec 31, 2017$28.47M+32.5%
Q4 FY2017CQ3 2017Sep 30, 2017$24.42M+11.2%
Q3 FY2017CQ2 2017Jun 30, 2017$21.57M-6.3%
Q2 FY2017CQ1 2017Mar 31, 2017$21.33M–
Q1 FY2017CQ4 2016Dec 31, 2016$21.48M–
Q4 FY2016CQ3 2016Sep 30, 2016$21.95M–
Q3 FY2016CQ2 2016Jun 30, 2016$23.01M–

More Citius Pharmaceuticals figures

See a number that looks wrong?